Clinical Trial Update: Ultra-long Acting Bronchodilator Therapy in Smoking Asthmatics [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on ultra-long acting bronchodilator therapy in smoking asthmatics has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: University of Dundee | Conditions: Asthma | Phase 4 | Status: COMPLETED